IHC of paraffin-embedded Carcinoma of Human prostate tissue using anti-RTN4IP1 mouse monoclonal antibody.
IHC of paraffin-embedded Human lymphoma tissue using anti-RTN4IP1 mouse monoclonal antibody.
IHC of paraffin-embedded Human lymph node tissue using anti-RTN4IP1 mouse monoclonal antibody.
IHC of paraffin-embedded Human pancreas tissue using anti-RTN4IP1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-RTN4IP1 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-RTN4IP1 mouse monoclonal antibody.
IHC of paraffin-embedded Human Kidney tissue using anti-RTN4IP1 mouse monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RTN4IP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RTN4IP1.
Flow cytometry of Jurkat cells, using anti-RTN4IP1 antibody (Red), compared to a nonspecific negative control antibody (Blue).
Flow cytometry of HeLa cells, using anti-RTN4IP1 antibody (Red), compared to a nonspecific negative control antibody (Blue).
HEK293T cells transfected with either overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-RTN4IP1 antibody, and then analyzed by flow cytometry.